Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price fell 1.4% on Wednesday . The company traded as low as GBX 81.36 and last traded at GBX 81.36. 26,333 shares changed hands during trading, a decline of 37% from the average session volume of 41,983 shares. The stock had previously closed at GBX 82.50.
Arecor Therapeutics Trading Down 1.4%
The company has a 50 day moving average of GBX 79.10 and a 200-day moving average of GBX 70.28. The stock has a market cap of £30.72 million, a price-to-earnings ratio of -3.54 and a beta of -0.18. The company has a debt-to-equity ratio of 5.51, a quick ratio of 6.24 and a current ratio of 1.37.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products. The Arestat™ platform is supported by an extensive patent portfolio.
Recommended Stories
- Five stocks we like better than Arecor Therapeutics
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
